| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

Principles for prioritizing dossiers within WHO prequalification of medicines

Medicine Update

27 October, 2011 - 09:00 (CEST)

This note outlines the basic principles applied by PQP for prioritization of product dossier assessments and inspections of related sites within each therapeutic area.

Important note regarding WHO public assessment reports (WHOPARs)

Medicine Update

7 October, 2011 - 09:00 (CEST)

The product information is an essential part of the medicinal product. The SmPC and PIL published with the WHOPAR have been quality assured by WHO experts and reflect the si

Additional information regarding falsified lamivudine, zidovudine and nevirapine tablets (Zidolam - N) in Kenya

Alerts

6 October, 2011 - 09:00 (CEST)

ASAQ Winthrop tablets batch recall

Alerts

4 October, 2011 - 09:00 (CEST)

Falsified lamivudine, zidovudine and nevirapine tablets (Zidolam - N) in Kenya

Alerts

22 September, 2011 - 09:00 (CEST)

New invitation for expression of interest (EOI) for antimalarial medicines published

Announcement

12 August, 2011 - 09:00 (CEST)

Malaria - 9^th Invitation for EOI [pdf]

Notice of concern (NOC) for Themis Medicare Limited published

Alerts

13 June, 2011 - 09:00 (CEST)

Themis Medicare Limited (8 June 2011), Gujarat - INDIA [pdf]

Notice of concern (NOC) for Amsal Chem Private Ltd published

Alerts

16 May, 2011 - 09:00 (CEST)

Amsal Chem Private Ltd (11 May 2011), Gujarat - INDIA [pdf]

One-third of antimalarial medicines tested in six African countries fail to meet international quality standards

Alerts

25 February, 2011 - 08:00 (CET)

Points to consider for inspections of biowaiver data

Medicine Update

16 December, 2010 - 08:00 (CET)

The WHO Prequalification of Medicines Programme (PQP) intends to include in its inspection programme, sites that have performed comparative dissolution studies submitted in prod

Subscribe to